Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: A case-control study from Italy

Annals of Epidemiology

Volumn 15, Issue 7, 2005, Pages 545-550

  Naldi, Luigi ^a   Altieri, Andrea ^b   Imberti, Gian Lorenzo ^a   Giordano, Laura ^b   Gallus, Silvano ^b   La Vecchia, Carlo ^b,c  

^a Bergamo General Hospital   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Cutaneous Malignant Melanoma; Hormones; Melanocytic Nevi; Menopause; Skin Pigmentation; Sunburn; Women

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ABORTION; ADULT; ARTICLE; BIRTH; BODY MASS; BODY SURFACE; CANCER RISK; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE COLOR; FEMALE; HISTOLOGY; HORMONAL THERAPY; HOSPITAL ADMISSION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MELANOCYTIC NEVUS; MELANOMA; MENOPAUSE; MENSTRUATION; ORAL CONTRACEPTION; PHENOTYPE; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; STATISTICAL SIGNIFICANCE; SUN EXPOSURE;

ADULT; AGE FACTORS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HORMONES; HUMANS; INTERVIEWS; ITALY; MELANOMA; MENSTRUATION; MIDDLE AGED; PHENOTYPE; QUESTIONNAIRES; REPRODUCTION; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; SKIN PIGMENTATION; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 22144487302     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2004.10.005     Document Type: Article

References (41)

1. R.S. Snell, and P.G. Bischitz The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation J Invest Dermatol 35 1960 73 82
2. J.E. Jelinek Cutaneous side effects of oral contraceptives Arch Dermatol 101 1970 181 186
3. S. Franceschi, A.E. Baron, and C. La Vecchia The influence of female hormones on malignant melanoma Tumori 76 1990 439 449
4. B.S. Schoenberg, and B.W. Christine Malignant melanoma associated with breast cancer South Med J 73 1980 1493 1497
5. H.A. Weiss, L.A. Brinton, N.A. Potischman, D. Brogan, R.J. Coates, and M.D. Gammon Breast cancer risk in young women and history of selected medical conditions Int J Epidemiol 28 1999 816 823
6. F. Levi, V.C. Te, L. Randimbison, and C. La Vecchia Cancer risk in women with previous breast cancer Ann Oncol 14 2003 71 73
7. B.K. Armstrong, and D.R. English Cutaneous malignant melanoma D. Schottenfeld J.F. Fraumeni Cancer Epidemiology and Prevention 2nd ed. 1996 Oxford University Press New York 1281 1312
8. V. Beral, S. Evans, H. Shaw, and G. Milton Oral contraceptive use and malignant melanoma in Australia Br J Cancer 50 1984 681 685
9. C. Bain, C.H. Hennekens, F.E. Speizer, B. Rosner, W. Willett, and C. Belanger Oral contraceptive use and malignant melanoma J Natl Cancer Inst 68 1982 537 539
10. P.C. Hannaford, L. Villard-Mackintosh, M.P. Vessey, and C.R. Kay Oral contraceptives and malignant melanoma Br J Cancer 63 1991 430 433
11. M.A. Smith, J.A. Fine, R.L. Barnhill, and M. Berwick Hormonal and reproductive influences and risk of melanoma in women Int J Epidemiol 27 1998 751 757
12. J. Westerdahl, H. Olsson, A. Masback, C. Ingvar, and N. Jonsson Risk of malignant melanoma in relation to drug intake, alcohol, smoking, and hormonal factors Br J Cancer 73 1996 1126 1131
13. M.R. Karagas, T.A. Stukel, J. Dykes, J. Miglionico, M.A. Greene, and M. Carey A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use Br J Cancer 86 2002 1085 1092
14. E.A. Holly, N.S. Weiss, and J.M. Liff Cutaneous melanoma in relation to exogenous hormones and reproductive factors J Natl Cancer Inst 70 1983 827 831
15. M.G. Le, P.A. Cabanes, V. Desvignes, M.F. Chanteau, N. Mlika, and M.F. Avril Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women Cancer Causes Control 3 1992 199 205
16. D. Feskanich, D.J. Hunter, W.C. Willett, D. Spiegelman, M.J. Stampfer, and F.E. Speizer Oral contraceptive use and risk of melanoma in premenopausal women Br J Cancer 81 1999 918 923
17. M. Lambe, M. Thorn, P. Sparen, R. Bergstrom, and H.O. Adami Malignant melanoma: Reduced risk associated with early childbearing and multiparity Melanoma Res 6 1996 147 153
18. R.P. Gallagher, J.M. Elwood, G.B. Hill, A.J. Coldman, W.J. Threlfall, and J.J. Spinelli Reproductive factors, oral contraceptives, and risk of malignant melanoma: Western Canada Melanoma Study Br J Cancer 52 1985 901 907
19. A. Green, and C. Bain Hormonal factors and melanoma in women Med J Aust 142 1985 446 448
20. A. Osterlind, M.A. Tucker, B.J. Stone, and O.M. Jensen The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women Int J Cancer 42 1988 821 824
21. E.A. Holly, R.D. Cress, and D.K. Ahn Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use Am J Epidemiol 141 1995 943 950
22. M.B. Veierod, E. Weiderpass, M. Thorn, J. Hansson, E. Lund, B. Armstrong, and H.O. Adami A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women J Natl Cancer Inst 95 2003 1530 1538
23. C.S. Kirkpatrick, E. White, and J.A. Lee Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity Am J Epidemiol 139 1994 869 880
24. S.D. Walter, R. Ashbolt, T. Dwyer, and L.D. Marrett Do larger people have more naevi? Naevus frequency versus naevus density Int J Epidemiol 29 2000 1025 1030
25. I. Thune, A. Olsen, G. Albrektsen, and S. Tretli Cutaneous malignant melanoma: Association with height, weight and body-surface area. A prospective study in Norway Int J Cancer 55 1993 555 561
26. E.A. Holly, D.A. Aston, R.D. Cress, D.K. Ahn, and J.J. Kristiansen Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors Am J Epidemiol 141 1995 934 942
27. L. Naldi, L.G. Imberti, F. Parazzini, S. Gallus, and C. La Vecchia Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: Results of a collaborative case-control study Cancer 88 2000 2703 2710
28. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-Control Studies. Lyon, France: IARC Scientific Publication No. 32; 1980.
29. A. Decarli, C. La Vecchia, E. Negri, and S. Franceschi Age at any birth and breast cancer in Italy Int J Cancer 67 1996 187 189
30. E. Kjems, and C. Krag Melanoma and pregnancy. A review Acta Oncol 32 1993 371 378
31. R. Zanetti, S. Franceschi, S. Rosso, E. Bidoli, and S. Colonna Cutaneous malignant melanoma in females: The role of hormonal and reproductive factors Int J Epidemiol 19 1990 522 526
32. J.M. Bliss, D. Ford, A.J. Swerdlow, B.K. Armstrong, M. Cristofolini, and J.M. Elwood Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE) Int J Cancer 62 1995 367 376
33. J. Lock-Andersen, K.T. Drzewiecki, and H.C. Wulf Eye and hair colour, skin type, and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study Acta Derm Venereol 79 1999 74 80
34. P. Carli, A. Biggeri, and B. Giannotti Malignant melanoma in Italy. Risks associated with common and clinically atypical melanocytic nevi J Am Acad Dermatol 32 1995 734 737
35. C. Garbe, P. Buttner, J. Weiss, H.P. Soyer, U. Stocker, and S. Krüger Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: Multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society J Invest Dermatol 102 1994 695 699
36. J.J. Grob, J. Gouvernet, D. Aymar, A. Mostaque, M.H. Romano, and A.M. Collet Count of benign melanocytic nevi as a major indicator of risk for non-familial nodular and superficial melanoma Cancer 66 1990 387 395
37. A.E. Grulich, V. Bataille, A.J. Swerdlow, J.A. Newton-Bishop, J. Cuzick, and P. Hersey Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: A case-control study in New South Wales, Australia Int J Cancer 67 1996 485 491
38. V. Bataille, J.A. Bishop, P. Sasieni, A.J. Swerdlow, E. Pinney, and K. Griffiths Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: A case-control study Br J Cancer 73 1996 1605 1611
39. M.A. Tucker, A. Halpern, E.A. Holly, P. Hartge, D.E. Elder, and R.W. Sagebiel Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma JAMA 277 1997 1439 1444
40. M.A. Tucker, and A.M. Goldstein Melanoma etiology: Where are we? Oncogene 22 2003 3042 3052
41. V. Chaudru, A. Chompret, B. Bressac-de Paillerets, A. Spatz, M.F. Avril, and F. Demenais Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families J Natl Cancer Inst 96 2004 785 795